Your browser doesn't support javascript.
loading
Impaired eIF5A function causes a Mendelian disorder that is partially rescued in model systems by spermidine.
Faundes, Víctor; Jennings, Martin D; Crilly, Siobhan; Legraie, Sarah; Withers, Sarah E; Cuvertino, Sara; Davies, Sally J; Douglas, Andrew G L; Fry, Andrew E; Harrison, Victoria; Amiel, Jeanne; Lehalle, Daphné; Newman, William G; Newkirk, Patricia; Ranells, Judith; Splitt, Miranda; Cross, Laura A; Saunders, Carol J; Sullivan, Bonnie R; Granadillo, Jorge L; Gordon, Christopher T; Kasher, Paul R; Pavitt, Graham D; Banka, Siddharth.
Afiliação
  • Faundes V; Division of Evolution & Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
  • Jennings MD; Laboratorio de Genética y Enfermedades Metabólicas, Instituto de Nutrición y Tecnología de los Alimentos (INTA), Universidad de Chile, Santiago, Chile.
  • Crilly S; Division of Molecular and Cellular Function, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
  • Legraie S; Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
  • Withers SE; Division of Neuroscience & Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
  • Cuvertino S; Division of Evolution & Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
  • Davies SJ; Division of Neuroscience & Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
  • Douglas AGL; Division of Evolution & Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
  • Fry AE; Institute of Medical Genetics, University Hospital of Wales, Cardiff, UK.
  • Harrison V; Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, UK.
  • Amiel J; Human Development and Health, Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton, UK.
  • Lehalle D; Institute of Medical Genetics, University Hospital of Wales, Cardiff, UK.
  • Newman WG; Division of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, UK.
  • Newkirk P; Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, UK.
  • Ranells J; Department of Genetics, AP-HP, Hôpital Necker Enfants Malades, Paris, France.
  • Splitt M; 1Laboratory of Embryology and Genetics of Human Malformations, INSERM UMR 1163, Institut Imagine, Paris, France.
  • Cross LA; Paris Descartes-Sorbonne Paris Cité University, Institut Imagine, Paris, France.
  • Saunders CJ; Department of Genetics, AP-HP, Hôpital Necker Enfants Malades, Paris, France.
  • Sullivan BR; Division of Evolution & Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
  • Granadillo JL; Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, UK.
  • Gordon CT; Division of Genetics and Metabolism, Department of Pediatrics, University of South Florida, Tampa, FL, UK.
  • Kasher PR; Division of Genetics and Metabolism, Department of Pediatrics, University of South Florida, Tampa, FL, UK.
  • Pavitt GD; Northern Genetics Service, Institute of Genetic Medicine, Newcastle upon Tyne, UK.
  • Banka S; Division of Clinical Genetics, Children's Mercy, Kansas City, MO, USA.
Nat Commun ; 12(1): 833, 2021 02 05.
Article em En | MEDLINE | ID: mdl-33547280
The structure of proline prevents it from adopting an optimal position for rapid protein synthesis. Poly-proline-tract (PPT) associated ribosomal stalling is resolved by highly conserved eIF5A, the only protein to contain the amino acid hypusine. We show that de novo heterozygous EIF5A variants cause a disorder characterized by variable combinations of developmental delay, microcephaly, micrognathia and dysmorphism. Yeast growth assays, polysome profiling, total/hypusinated eIF5A levels and PPT-reporters studies reveal that the variants impair eIF5A function, reduce eIF5A-ribosome interactions and impair the synthesis of PPT-containing proteins. Supplementation with 1 mM spermidine partially corrects the yeast growth defects, improves the polysome profiles and restores expression of PPT reporters. In zebrafish, knockdown eif5a partly recapitulates the human phenotype that can be rescued with 1 µM spermidine supplementation. In summary, we uncover the role of eIF5A in human development and disease, demonstrate the mechanistic complexity of EIF5A-related disorder and raise possibilities for its treatment.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Deficiências do Desenvolvimento / Fatores de Iniciação de Peptídeos / Proteínas de Ligação a RNA / Regulação da Expressão Gênica no Desenvolvimento / Microcefalia / Micrognatismo Tipo de estudo: Etiology_studies / Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Deficiências do Desenvolvimento / Fatores de Iniciação de Peptídeos / Proteínas de Ligação a RNA / Regulação da Expressão Gênica no Desenvolvimento / Microcefalia / Micrognatismo Tipo de estudo: Etiology_studies / Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article